In vitro drug susceptibility of Chlamydia sp. strain TWAR
Open Access
- 1 February 1988
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 32 (2) , 257-258
- https://doi.org/10.1128/aac.32.2.257
Abstract
The in vitro susceptibilities of eight Chlamydia sp. strain TWAR isolates were tested against tetracycline, erythromycin, penicillin, ampicillin, sulfisoxazole, and a new drug, trospectomycin. The ranges of inhibitory concentrations of these antimicrobial agents, except for sulfonamide, were similar to those for Chlamydia trachomatis. Sulfisoxazole was not inhibitory at the highest nontoxic concentration tested.This publication has 11 references indexed in Scilit:
- Characterization of the new Chlamydia agent, TWAR, as a unique organism by restriction endonuclease analysis and DNA-DNA hybridizationJournal of Clinical Microbiology, 1987
- Unique ultrastructure in the elementary body of Chlamydia sp. strain TWARJournal of Bacteriology, 1987
- Pneumonia Associated with the TWAR Strain of ChlamydiaAnnals of Internal Medicine, 1987
- Identification of a new group of Chlamydia psittaci strains called TWARJournal of Clinical Microbiology, 1986
- A NewChlamydia psittaciStrain, TWAR, Isolated in Acute Respiratory Tract InfectionsNew England Journal of Medicine, 1986
- Sensitivity of immunofluorescence with monoclonal antibodies for detection of Chlamydia trachomatis inclusions in cell cultureJournal of Clinical Microbiology, 1982
- In vitro assays of the efficacy of antimicrobial agents in controlling Chlamydia trachomatis propagationAntimicrobial Agents and Chemotherapy, 1978
- Antimicrobial Activity of Several Antibiotics and a Sulfonamide Against Chlamydia trachomatis Organisms in Cell CultureAntimicrobial Agents and Chemotherapy, 1977